Transition Aktie
WKN DE: A3EVME / ISIN: FR001400JWR8
|
23.05.2026 23:07:00
|
Phibro's CEO transition puts this insider sale in context
Jack Bendheim, President and CEO of Phibro Animal Health Corporation (NASDAQ:PAHC), disclosed the indirect sale of 18,608 shares of Common Stock across multiple open-market transactions from May 5, 2026 through May 7, 2026, as reported in the SEC Form 4 filing.Transaction value based on SEC Form 4 weighted average purchase price ($54.61); post-transaction value based on total reported shares multiplied by the final May 7, 2026 close price, as calculated in SEC data.* 1-year performance calculated using May 7th, 2026 as the reference date.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Transition
Analysen zu Transition
Aktien in diesem Artikel
| Transition | 8,88 | 21,31% |
|